82 related articles for article (PubMed ID: 8706012)
1. A new process of cancer prevention mediated through inhibition of tumor necrosis factor alpha expression.
Suganuma M; Okabe S; Sueoka E; Iida N; Komori A; Kim SJ; Fujiki H
Cancer Res; 1996 Aug; 56(16):3711-5. PubMed ID: 8706012
[TBL] [Abstract][Full Text] [Related]
2. Canventol inhibits tumor promotion in CD-1 mouse skin through inhibition of tumor necrosis factor alpha release and of protein isoprenylation.
Komori A; Suganuma M; Okabe S; Zou X; Tius MA; Fujiki H
Cancer Res; 1993 Aug; 53(15):3462-4. PubMed ID: 8339247
[TBL] [Abstract][Full Text] [Related]
3. A new tumor promotion pathway and its inhibitors.
Fujiki H; Suganuma M; Komori A; Yatsunami J; Okabe S; Ohta T; Sueoka E
Cancer Detect Prev; 1994; 18(1):1-7. PubMed ID: 8162603
[TBL] [Abstract][Full Text] [Related]
4. A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea--a review.
Fujiki H; Suganuma M; Okabe S; Sueoka E; Suga K; Imai K; Nakachi K
Cancer Detect Prev; 2000; 24(1):91-9. PubMed ID: 10757128
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
Suganuma M; Okabe S; Kai Y; Sueoka N; Sueoka E; Fujiki H
Cancer Res; 1999 Jan; 59(1):44-7. PubMed ID: 9892181
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation.
Komori A; Yatsunami J; Suganuma M; Okabe S; Abe S; Sakai A; Sasaki K; Fujiki H
Cancer Res; 1993 May; 53(9):1982-5. PubMed ID: 8481899
[TBL] [Abstract][Full Text] [Related]
7. New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen.
Fujiki H; Suganuma M; Kurusu M; Okabe S; Imayoshi Y; Taniguchi S; Yoshida T
Mutat Res; 2003; 523-524():119-25. PubMed ID: 12628509
[TBL] [Abstract][Full Text] [Related]
8. Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of mRNA expression of an endogenous tumor promoter TNF alpha.
Zi X; Mukhtar H; Agarwal R
Biochem Biophys Res Commun; 1997 Oct; 239(1):334-9. PubMed ID: 9345320
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
11. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
Zins K; Abraham D; Sioud M; Aharinejad S
Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
Fujimoto N; Sueoka N; Sueoka E; Okabe S; Suganuma M; Harada M; Fujiki H
Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression.
Suganuma M; Sueoka E; Sueoka N; Okabe S; Fujiki H
Biofactors; 2000; 13(1-4):67-72. PubMed ID: 11237202
[TBL] [Abstract][Full Text] [Related]
14. Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity.
Bruccoleri A; Gallucci R; Germolec DR; Blackshear P; Simeonova P; Thurman RG; Luster MI
Hepatology; 1997 Jan; 25(1):133-41. PubMed ID: 8985279
[TBL] [Abstract][Full Text] [Related]
15. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
[TBL] [Abstract][Full Text] [Related]
16. Translational research on TNF-alpha as an endogenous tumor promoter and green tea as cancer preventive in humans.
Fujiki H; Suganuma M
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(1):3-30. PubMed ID: 16304719
[No Abstract] [Full Text] [Related]
17. Effects of acanthoic acid on TNF-alpha gene expression and haptoglobin synthesis.
Kang HS; Song HK; Lee JJ; Pyun KH; Choi I
Mediators Inflamm; 1998; 7(4):257-9. PubMed ID: 9792335
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung.
Zhang M; Qian J; Xing X; Kong FM; Zhao L; Chen M; Lawrence TS
Clin Cancer Res; 2008 Mar; 14(6):1868-76. PubMed ID: 18347190
[TBL] [Abstract][Full Text] [Related]
19. Prevention of carcinogenesis of mouse mammary epithelial cells RIII/MG by epigallocatechin gallate.
Yanaga H; Fujii T; Koga T; Araki R; Shirouzu K
Int J Mol Med; 2002 Sep; 10(3):311-5. PubMed ID: 12165806
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
Kim CH; Moon SK
Arch Biochem Biophys; 2005 Mar; 435(2):264-72. PubMed ID: 15708369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
